Search results

Found 1,514 pages
AUTHOR: Anna Smith

Results per page

10 20 50 100

Sort by

Relevance Date

16 Aug 2019:

Rozlytrek bags FDA approval

For the indication of ROS1-positive, metastatic non-small cell lung cancer (NSCLC). - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/rozlytrek_bags_fda_approval_1297771

9 Apr 2019:

GSK’s HIV drug Dovato gets FDA approval

It marks the  first two-drug complete regimen for HIV-infected patients. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/gsks_hiv_drug_dovato_gets_fda_approval_1284064

19 Aug 2019:

Rinvoq bags FDA green light

In the SELECT programme, the oral JAK inhibitor met all primary and ranked secondary endpoints across a variety of rheumatoid arthritis patients. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/rinvoq_bags_fda_green_light_1298039

30 Jul 2019:

£3m funding for MS, Parkinson’s

The money will go to a new UK ‘digital brain bank’, Europe’s largest brain and tissue bank, based in London. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/3m_funding_for_ms,_parkinsons_1295495

9 Apr 2019:

United Theraputics ends esuberaprost trial early

The company kept the announcement short, but said the study did not meet its primary endpoint. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/united_theraputics_ends_esuberaprost_trial_early_1284070

14 Aug 2019:

Ebola ‘no longer incurable’

Two new drugs, mAb114 and REGN-EB3, have been found to dramatically cut mortality from Ebola. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/ebola_no_longer_incurable_1297445

11 Sep 2019:

Merck initiates late-stage MS study

The previous Phase II trial met its primary endpoint. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/msd_initiates_late-stage_ms_study_1301294

22 Aug 2019:

Skyrizi bags NICE fast-track

Eligible patients in England and Wales will have access to the drug almost two months earlier. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/skyrizi_bags_nice_fast-track_1298714

4 Sep 2019:

Teva undergoes rebranding

The “refreshed visual identity” includes a new digital platform entitled ‘Life Effects’. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/teva_undergoes_rebranding_1300709

25 Jan 2019:

Rubraca gets EU approval

Clovis Oncology' Rubraca has been approved by the European Commission for maintenance treatment of adults with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/rubraca_gets_eu_approval_1276217